The effect of nacre extract on cord blood-derived endothelial progenitor cells: a natural stimulus to promote angiogenesis?

Fiche publication


Date publication

février 2019

Journal

Journal of biomedical materials research. Part A

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GILLET Pierre, Pr DECOT Véronique


Tous les auteurs :
Willemin AS, Zhang G, Velot E, Bianchi A, Decot V, Rousseau M, Gillet P, Moby V

Résumé

Angiogenesis is a critical parameter to consider for the development of tissue-engineered bone substitutes. The challenge is to promote sufficient vascularization in the bone substitute to prevent cell death and to allow its efficient integration. The capacity of nacre extract to restore the osteogenic activity of osteoarthritis osteoblasts has already been demonstrated. However, their angiogenic potential on endothelial progenitor cells (EPCs) was not yet explored. Therefore, the current study aimed at investigating if nacreous molecules affect EPC behavior. The gene and protein expression levels of endothelial cell-specific markers were determined in EPCs cultivated in presence of a nacre extract (Ethanol Soluble matrix (ESM) at two concentrations: 100μg/mL and 200μg/mL (respectively abbreviated ESM100 and ESM200)). Cell functionality was explored by proangiogenic factors production and in vitro tube formation assay. ESM200 increased the expression of some endothelial cell-specific genes. The in vitro tube formation assay demonstrated that ESM200 stimulated tubulogenesis affecting angiogenic parameters. We demonstrated that a stimulation with 200μg/mL of ESM increased angiogenesis key elements. This in vitro study strongly highlights the proangiogenic effect of ESM. Due to its osteogenic properties, previously demonstrated, ESM could constitute the key element to develop an ideal prevascularized bone substitute. This article is protected by copyright. All rights reserved.

Mots clés

angiogenesis, endothelial progenitor cells, ethanol soluble matrix, nacre, stimulus

Référence

J Biomed Mater Res A. 2019 Feb 8;: